|
Volumn 45, Issue 5, 2011, Pages 383-388
|
World gastroenterology organisation global guideline: Helicobacter pylori in developing countries
a a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
BISMUTH;
BISMUTH CITRATE;
CLARITHROMYCIN;
FURAZOLIDONE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
LEVOFLOXACIN;
METRONIDAZOLE;
NITROIMIDAZOLE;
OMEPRAZOLE;
PROTON PUMP INHIBITOR;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RABEPRAZOLE;
RIFABUTIN;
TETRACYCLINE;
TINIDAZOLE;
UREASE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ANTIGEN DETECTION;
ARTICLE;
BACTERIUM CULTURE;
BACTERIUM IDENTIFICATION;
BREATH ANALYSIS;
COST CONTROL;
DEVELOPING COUNTRY;
ENDOSCOPY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ERADICATION THERAPY;
FECES ANALYSIS;
GEOGRAPHIC DISTRIBUTION;
GOOD CLINICAL PRACTICE;
HEALTH CARE ORGANIZATION;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HISTOPATHOLOGY;
HUMAN;
INCIDENCE;
PEPTIC ULCER;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
SERODIAGNOSIS;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
CHILD, PRESCHOOL;
DEVELOPING COUNTRIES;
FEMALE;
GASTROENTEROLOGY;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
PREVALENCE;
RISK FACTORS;
YOUNG ADULT;
|
EID: 79955044649
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/MCG.0b013e31820fb8f6 Document Type: Article |
Times cited : (108)
|
References (0)
|